Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 2 open reading frame 76 (C2orf76) is a protein-coding gene of unknown or poorly characterized function in humans. It is not currently annotated as a therapeutic target such as a receptor, enzyme, transporter, or ion channel[3][1]. C2orf76 is listed in major protein and gene databases, and has associations with a variety of biological entities, tissues, and gene expression datasets, but there is no clear evidence for a specific molecular function, involvement in major signaling or regulatory pathways, or role in known human disease mechanisms[3][1][7]. Current data suggest that, if functional, it may be involved in gene regulatory or epigenetic mechanisms[1]. There are no known drugs, disease biomarkers, or clinical safety issues associated with this gene or its protein product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 2 open reading frame 76 (C2orf76).